1. Home
  2. MYGN vs RELY Comparison

MYGN vs RELY Comparison

Compare MYGN & RELY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.69

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Remitly Global Inc.

RELY

Remitly Global Inc.

HOLD

Current Price

$16.29

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
RELY
Founded
1991
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
3.0B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
MYGN
RELY
Price
$4.69
$16.29
Analyst Decision
Buy
Buy
Analyst Count
8
8
Target Price
$7.64
$24.13
AVG Volume (30 Days)
1.8M
3.2M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
263.16
EPS
N/A
0.31
Revenue
$771,400,000.00
$1,635,147,000.00
Revenue This Year
$7.19
$21.82
Revenue Next Year
$5.64
$19.08
P/E Ratio
N/A
$49.31
Revenue Growth
2.33
29.37
52 Week Low
$3.76
$12.08
52 Week High
$10.06
$24.63

Technical Indicators

Market Signals
Indicator
MYGN
RELY
Relative Strength Index (RSI) 44.55 54.57
Support Level $3.93 $15.62
Resistance Level $5.69 $17.81
Average True Range (ATR) 0.32 0.61
MACD 0.00 -0.20
Stochastic Oscillator 27.60 37.82

Price Performance

Historical Comparison
MYGN
RELY

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

Share on Social Networks: